您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
AKR1C4 Rabbit polyclonal antibody

AKR1C4 Rabbit polyclonal antibody

货号: S0B0667
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 分子别名

    Aldo-keto reductase family 1 member C4, 3-alpha-hydroxysteroid dehydrogenase type I (3-alpha-HSD1), 3alpha-hydroxysteroid 3-dehydrogenase, Chlordecone reductase (CDR), Dihydrodiol dehydrogenase 4 (DD-4; DD4), HAKRA, CHDR
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm
  • Accession

    P17516
  • 抗体类型

    Polyclonal antibody
  • 抗体同种型

    IgG
  • 应用

    WB
  • 反应种属 ?

    Hu
  • 纯化方式

    Immunogen Affinity
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度
WB 1:1000
背景介绍
  • AKR1C4 (Aldoketoreductase 1C4) is a multifunctional oxidoreductase that plays a crucial role in maintaining metabolic balance and regulating the conversion of biologically active substances into their active or inactive forms in the human body. AKR1C4 is involved in the metabolism of various steroid hormones, including androgens, estrogens, and progestins. It converts these hormones into their active or inactive forms, thereby influencing their biological activity and effects in the body. In addition to steroid hormones, AKR1C4 also participates in prostaglandin metabolism. Prostaglandins are essential biologically active lipids involved in various physiological and pathological processes, such as inflammation, pain, and vasoconstriction. AKR1C4 can also metabolize certain drugs, affecting their efficacy and clearance rate. This is crucial for understanding the pharmacokinetics and pharmacodynamics of drugs in the body. As an NADPH-dependent oxidoreductase, AKR1C4 plays a role in maintaining redox balance within cells, helping to protect them from oxidative stress damage. Recent studies have found abnormal expression of AKR1C4 in various cancers, such as prostate cancer and breast cancer. This makes AKR1C4 a potential disease marker and therapeutic target. By modulating AKR1C4 activity, it may be possible to control cancer development and improve treatment outcomes.

  • 免疫印迹

    • WB result of AKR1C4 Rabbit pAb
      Primary antibody: AKR1C4 Rabbit pAb at 1/1000 dilution
      Lane 1: HepG2 whole cell lysate 20 µg
      Lane 2: A549 whole cell lysate 20 µg
      Lane 3: Molt-4 whole cell lysate 20 µg
      Lane 4: HeLa whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 37 kDa
      Observed MW: 37 kDa